Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Takeover Thursday: Private equity’s top takeovers this month
Takeover Thursday: Private equity’s top takeovers this month Pets at Home shares soared 14 percent on February 26 following speculation that private equity firm BC Partners is preparing a takeover bid. Investor discussions intensified after multiple bid vehicles,...
Blackstone and Permira assess debt options for €6.5bn Adevinta deal
Blackstone and Permira assess debt options for €6.5bn Adevinta deal Blackstone and Permira are exploring debt financing options for Adevinta ASA, with banks and private credit lenders competing to provide up to €6.5bn ($6.8bn). The private equity firms aim to...
Update: Walgreens Boots buyout could lead to three-way breakup
Update: Walgreens Boots buyout could lead to three-way breakup A potential buyout of Walgreens Boots Alliance by Sycamore Partners is expected to pave the way for a three-way split of the struggling US pharmacy giant. Executive chair Stefano Pessina would likely...